Denver. Always interested in applied physiology and improvements in patient care, he wanted to see some of our home care patients who were receiving long term oxygen using a new portable oxygen system. He also wanted to view Pikes Peak and take photographs for teaching medical students and house officers in Edinburgh, being well aware of the fact that the Haldane expedition in 1913 to the summit (4300 metres) had helped to characterise the effects of substantial hypoxia on normal volunteers.
"Partial anoxia means not a mere slowing down of life but progressive and perhaps irreparable damage to living structure": this direct quote from Haldane's report in 1919 also describes, accurately and succinctly, the impact of oxygen lack on patients with chronic respiratory insufficiency. 2 Haldane was aware that the clinical manifestations of impaired oxygen transport to the tissues could be corrected with supplemental oxygen delivered via nasal cannulas. Flenley taught and wrote extensively on the physiology of tissue oxygen transport3 and thus wanted to experience and see the original laboratory used for the oxygen experiments in Colorado.
Our initial observations about long term oxygen were soon confirmed by a similar study from Birmingham, which appeared one year after our original report.4 Both came to the same conclusion-namely, that long term oxygen could reverse the pulmonary hypertension and control the erythrocytosis that were responses to chronic hypoxaemia in patients with chronic bronchitis and emphysema. Moreover, the sustained use of oxygen did not lead to uncompensated retention of carbon dioxide and respiratory acidosis, a feared but infrequent complication of oxygen therapy that was usually found only in the acutely ill patient with advanced chronic obstructive lung disease, applying to both chronic bronchitis and emphysema. Address The British Medical Research Council working party designed a very important clinical trial, which compared treatment with oxygen for 15 hours a day, including the hours of sleep, with no oxygen in terms of survival.6 Almost simultaneously North American colleagues designed a study that compared 12 hours of oxygen, including the hours of sleep, with nearly continuous oxygen from a portable system.7 These two monumental studies were reported about a year apart. The British study, in which David Flenley played a major part, showed a clear effect ofoxygen on survival when it was compared with no oxygen. The North American study (NOTT) showed that nearly continuous oxygen was superior to oxygen given for about half the time. As the demographic and physiological background factors were similar in the UK and NOTT studies, the outcomes could be compared. These comparisons dramatically showed that survival in patients with advanced chronic obstructive lung disease with stable hypoxaemia is poor without supplemental oxygen. Survival is better with oxygen given for either 12 or 15 hours a day than with no oxygen at all. But survival was far superior in the North American patients who received nearly continuous ambulatory oxygen. Together we reported these conclusions in a chapter of a book that we edited jointly.8 These two studies had a profound effect in stimulating the widespread use of domiciliary oxygen in North America and Europe, and gradually throughout the world. The next meeting of the International Oxygen Club in spring 1989 at the American Thoracic Society will be discussing the many controversies raised at these international conferences and society meetings that remained unanswered, such as the mechanisms for oxygen's survival benefit. Is it the achievement of normal or near normal oxygen saturation values throughout the day that explains the benefit? If, for example, an oxygen saturation of more than 92% could be achieved and sustained, would patients fare better than those who achieved something less than 90% oxygen saturation? Is survival solely a function of reduced pulmonary artery pressure and improved right ventricular function? Another unanswered question focuses on the question of the method of delivery of oxygen versus the duration of oxygen therapy. It is quite clear that the duration of oxygen administration resulted in the improved survival in the British study because the "no oxygen" control group did worse than those randomised to receive oxygen from a stationary source, usually high pressure cylinders. The improved survival in the North American study could, however, have been due to either the duration of treatment or the method of oxygen delivery. Half of the NOTT patients were randomly assigned to receive oxygen for about 12 hours a day from a stationary system (concentrators and tanks were used interchangeably), whereas the other half received oxygen for a longer period, almost 20 hours a day, from a portable system.
Patients who received oxygen while ambulant and away from home might have achieved superior physical or psychological fitness, which could have contributed to better survival.
It was in the midst of planning further controlled clinical trials to explain differences in outcome and to determine more clearly the indications for the use of oxygen that David Flenley died suddenly and unexpectedly in March this year. All who knew him, including those frequently drawn into vigorous yet sincere argumentative discussion, will miss his wit, humour, and insight. Our future studies will continue to be inspired by his dedication to excellence in clinical science and patient care. 
